Esmael, Mampai M.
HRN: 10-78-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/29/2024
04/04/2024
IV
500 Mg
Q 8 Hours
Obstruction
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes